This site is intended for health professionals only
Hospital Healthcare Europe
Register
Login
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
Home
>
Editor’s pick
Editor’s pick
Warning over drug combination
Senate to stop drug data mining
BIA welcomes UK Bioscience and Health Technology database report
Patients add to prescription errors
Cancer drug “helps relieve asthma”
Study results show associated improvements under treatment with Cimzia
Patients treated with Cimzia show improved quality of life
Celgene UK announce data evaluating continuous therapy with Revlimid at ASH
Novartis set to sustain its leading global position in oncology
Celgene International announce Revlimid data at ASH 2009
Velcade “boosts myeloma treatment”
FDA “yet to make Vioxx safety changes”
« Previous
1
…
94
95
96
97
98
…
302
Next »
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: